欢迎来到三一文库! | 帮助中心 三一文库31doc.com 一个上传文档投稿赚钱的网站
三一文库
全部分类
  • 幼儿/小学教育>
  • 中学教育>
  • 高等教育>
  • 研究生考试>
  • 外语学习>
  • 资格/认证考试>
  • 论文>
  • IT计算机>
  • 法律/法学>
  • 建筑/环境>
  • 通信/电子>
  • 医学/心理学>
  • ImageVerifierCode 换一换
    首页 三一文库 > 资源分类 > PPT文档下载
    分享到微信 分享到微博 分享到QQ空间

    药品研究中GLP实验室实验原始记录审核技术要求.ppt

    • 资源ID:136549       资源大小:3.30MB        全文页数:109页
    • 资源格式: PPT        下载积分:5
    快捷下载 游客一键下载
    账号登录下载
    微信登录下载
    三方登录下载: 微信开放平台登录 QQ登录 微博登录
    二维码
    微信扫一扫登录
    下载资源需要5
    邮箱/手机:
    温馨提示:
    快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。
    如填写123,账号就是123,密码也是123。
    支付方式: 支付宝    微信支付   
    验证码:   换一换

    加入VIP免费专享
     
    账号:
    密码:
    验证码:   换一换
      忘记密码?
        
    友情提示
    2、PDF文件下载后,可能会被浏览器默认打开,此种情况可以点击浏览器菜单,保存网页到桌面,就可以正常下载了。
    3、本站不支持迅雷下载,请使用电脑自带的IE浏览器,或者360浏览器、谷歌浏览器下载即可。
    4、本站资源下载后的文档和图纸-无水印,预览文档经过压缩,下载后原文更清晰。
    5、试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。

    药品研究中GLP实验室实验原始记录审核技术要求.ppt

    1、药品研究中药品研究中GLPGLP实验室实验室实验原始记录审核技术要求实验原始记录审核技术要求龚兆龙博士龚兆龙博士资深副总裁兼首席技术官资深副总裁兼首席技术官资深副总裁兼首席技术官资深副总裁兼首席技术官昭衍新药研究中心昭衍新药研究中心1新药研发过程新药研发过程2新药研发过程质量规范新药研发过程质量规范GLP历史沿革历史沿革遵从遵从GLP的意义的意义GLP规范基本要求规范基本要求原始数据核查要点原始数据核查要点非临床实验室常见错误非临床实验室常见错误法规对法规对GLP或非或非GLP的要求的要求案例分析案例分析内容提要内容提要4GLP历史历史美国美国WhatpromptedUSFDAtoissueG

    2、LPregulations?Inthe1960sand1970s,inadditiontothe“Thalidomide”story,FDAfound:SelectivelysubmittedfindingsFabricateddataFalsifieddataDiscrepanciesinreporting(e.g.,betweenindividualandsummarydata)Poorlaboratoryrecordkeeping(resultingininabilitytoreconstructstudyperformance)GLP历史历史美国美国In the 1960s and 1

    3、970s,FDA also found:Noprotocols,protocolswrittenafterstudyperformance,studynotperformedaccordingtoprotocolNooneinchargeofstudiesSloppylaboratorypracticesUSFDAGLP法规法规1976CongressionalhearingsGLPsproposed1978GLPsfinalized1979GLPsbecomeeffectiveUSFDAGLP法规法规 21CFR:CodeofFederalRegulations,Food&DrugAdmin

    4、istration.21CFRPart58:GoodLaboratoryPracticesforNonclinicalLaboratoryStudies21CFRPart11:ElectronicRecords;ElectronicSignaturesUSFDAGLPPart58要求要求Describes requirements for conducting and reporting nonclinical laboratory studiesIntent:provides a framework for conducting well-controlled studiesassures

    5、quality and integrity of the datafacilitates study reconstructionprovides overall accountability Nonclinical studies that evaluate safety must be GLP compliantUSFDAGLP检查检查FDAGLP检查过的美国国内实验室检查过的美国国内实验室200余家余家,CRO,药厂药厂USFDAGLP检查检查FDAGLP检查过的美国境外实验室检查过的美国境外实验室40余家余家,CRO,药厂药厂USFDAGLP检查:检查:MOU8个国家个国家日本日本法国

    6、法国德国德国加拿大加拿大意大利意大利瑞典瑞典瑞士瑞士荷兰荷兰USFDAGLP检查:中国检查:中国GLP实验室实验室2009年年7月月检查了三家了三家GLP实验室室国家安国家安评中心中心(NCSED)昭衍(昭衍(JOINN)Bridge(康康龙化成化成)昭衍提交的昭衍提交的试验报告告获得美国得美国FDA认可可,用于支持美国的用于支持美国的临床床试验。OECDGLP规范规范Developedin1978USFDAGLPprovidedthebasisforOECDRevisedOECDprinciplesadoptedin1997PrimaryobjectivesimilartoUSFDAToen

    7、surethegenerationofhighqualityandreliabletestdatarelatedtothesafetyofindustrialchemicalsubstancesandpreparationsintheframeworkofharmonisingtestingproceduresforthemutualacceptanceofdata(MAD)OECDMAD(数据互认)(数据互认)DatageneratedinthetestingofchemicalsinanOECDmembercountryinaccordancewithOECDTestGuidelinesa

    8、ndOECDPrinciplesofGLPshallbeacceptedinotherMembercountriesforpurposesofassessmentandotherusesrelatingtotheprotectionofmanandtheenvironmentOECDMemberCountriesAustralia,Austria,Belgium,Canada,CzechRepublic,Denmark,Finland,France,Germany,Greece,Hungary,Iceland,Ireland,Italy,Japan,Korea,Luxembourg,Mexic

    9、o,Netherlands,NewZealand,Norway,Poland,Portugal,SlovakRepublic,Spain,Sweden,Switzerland,Turkey,UnitedKingdom,UnitedStates中国中国GLP发展历史发展历史1993年年12月,国家科委发布了月,国家科委发布了GLP(试行)(试行)1999年年10月,月,SDA发布发布GLP(试行)(试行)2001年中国修订年中国修订中华人民共和国药品管理法中华人民共和国药品管理法、药品法实施条例药品法实施条例,将,将GLP明确为法定要求明确为法定要求2003年年9月月,SFDA颁布实施颁布实施G

    10、LP(二号令)(二号令)280条条,开展开展GLP认证检查认证检查2007年年1月月法规毒理实验强制要求法规毒理实验强制要求GLP2009年年7月月3家在中国的家在中国的GLP实验室接受美国实验室接受美国FDA检查检查中国中国GLP管理规范管理规范药物非临床研究质量管理规范(局令第药物非临床研究质量管理规范(局令第2号)号)2003年年9自自2003年年9月月1日起施行日起施行共九章共九章45条条非临床研究质量管理规范认证标准非临床研究质量管理规范认证标准280条条药品注册现场核查管理规定药品注册现场核查管理规定7章、章、59条、条、5个附件个附件遵从遵从GLP的意义的意义Assuresqua

    11、litydataanddataintegrityProtectsthewell-beingofsubjectsinclinicaltrialsmanyofwhomarehealthyvolunteers(humansafety)Ensuresthatastudycanbecompletelyreconstructedfromarchivedrecords对中国对中国CRO来说,研究报告可以得到国际来说,研究报告可以得到国际认可。认可。GLP规范要素规范要素Whatisanonclinicallaboratory?IntheSFDAorUSFDAregulatoryworld,alaborato

    12、riesthatconductnonclinicalstudiesinvolvingtestarticlestodevelopdatathatwillbesubmittedtotheagencyinsupportofanapplicationandmarketingapprovalGLP规范要素规范要素TestArticlestheSFDA-/USFDA-regulatedproductbeingtestedGLP规范要素规范要素TestSystemsMouse/Rat,GuineaPig,Rabbit,Dog(Beagle),Pig,Monkey,Primate,(Chimpanzee)Th

    13、eABCofGLPRegulationsDefinitionsPersonIndividualPartnershipGovernmentagencyOrganizationalunitCorporationScientificoracademicestablishmentGLP规范要素规范要素RawDataLaboratoryworksheetsRecords&documentMemorandaNotesComputerprint-outsAllcommunications(internal/external/sponsors)GLP规范要素规范要素OrganizationandPersonn

    14、elEducationTrainingExperienceJobdescriptionPersonnelRecordPersonnelManagementStudyDirectorQAUFollowprotocolDocumentdeviationsArchiveGLP规范要素规范要素OrganizationandPersonnelReviewQAUPersonnelStudyDirectorMasterschedulesheetProtocolsInspectionrecordsSOPsManagementStatusreportFinalstudyreportGLP规范要素规范要素Faci

    15、litiesNonclinicallaboratoryReceiptandstorageMixingGLP现场核查现场核查Process-orientedqualitydataasaresultofproperutilizationofandcontroloverfacilities,personnelandproceduresAllowsflexibilityinlaboratoryoperationanduseofscientificjudgmentstudydirectorsmustexertthisjudgmentoverallresponsibilityfortechnicalcon

    16、duct,interpretationandreporting现场核查要点现场核查要点Step1:InventoryDocuments文件清单文件清单MakesurenecessarydocumentswereincludedinthestudyreportProtocolProtocolamendments方案修改方案修改Protocoldeviations方案偏离方案偏离(withexplanationsonpossibleimpacttostudyinterpretationandvalidity)Report(withsufficientlydetailedsummaryandindi

    17、vidualanimaldata)现场核查要点现场核查要点Step2:Identifytestarticle供试品供试品testarticlecodeornamesaltformformulationpurityUniformity均一性均一性Stability稳定性稳定性lotorbatch#现场核查要点现场核查要点Step3:Theexperimentaldesign试验设计试验设计Studiesarefluid;whatisinaprotocolfrequentlychangesduringthecourseofastudyNoteimportantdates(experimentald

    18、esignlandmarks)experimentalordosingstartdate(REPORT)studyinitiationdate(REPORT)protocolamendmentdate(s)(AMENDMENTS)experimentalcompletiondate/necropsydate(REPORT)现场核查要点现场核查要点Step3:Theexperimentaldesign试验设计试验设计Notehowexperimentaldesign/methodschangedlookatprotocolamendmentsanddeviationsconsiderifthec

    19、hangesinvalidatedthestudysobjectivesconsiderifthechangescausedstudytobeinconsistentwithstatedguidelines/methods(andevaluatesignificance)Makesureyouunderstandexperimentaldesign(as performed)andchronologyperamendmentsanddocumenteddeviations现场核查要点现场核查要点Step4:Comparedocumentsforconsistency 一致性一致性Dorepor

    20、tscomplywithGLPrequirementsonreportingfortestarticlecharacteristicstestingofdosingformulationsforpuritystabilityuniformity现场核查要点现场核查要点Step4:Comparedocumentsforconsistency Makesurethatdataandtheirassociateddocumentsareconsistentwithoneanother.现场核查要点现场核查要点Step4:Comparedocumentsforconsistency Areprotoc

    21、ol-specifiedevaluationsofdataapplied?statisticaltestscriteriaforacceptablestudy,positivefinding(e.g.,genotoxicitytests)Doesselectionofhighestdosecomplywithprotocol?Withreferencedguideline?现场核查要点现场核查要点Step4:ComparedocumentsforconsistencyArefindingsforallprotocol-specifiedevaluationsreportedbodyweight

    22、clinicalchemistryhistopathologyforallprotocol-specifieddosegroupstoxicokinetics现场核查要点现场核查要点Step5:Dodataseemcredible?ReportRawdata/Reality现场核查要点现场核查要点Step6:Evaluationofsignificanceoflapses失误的评估失误的评估ThebigquestionsDidproblemsinstudydocumentsresultinyourinabilitytodrawmeaningfulconclusionsfromthestudy(

    23、withrespecttostudysstatedobjective)?Didinconsistenciesinthispartofthesubmission,relativetootherpartsofthesubmission,makeyouhavelessfaithintheintegrityofotherportionsofthesubmission?Intheconclusionsofotherstudies?现场核查要点现场核查要点Notalllapsesprecludedrawingconclusionsfromastudymistakescanhappeninperformin

    24、gastudyindescribingfactsometimesfactisnotconvenientTheevaluationofmistakesrequiresanevalutionoftheirmagnitudeandnature.Areerrorswidespread?Limited?Doerrorsoccurinreportingofendpointsthatarecriticaltoscientificinterpretation?Doerrorsspeakforareport-specificproblemorsomethingthatisasystemicproblem?现场核

    25、查要点:职责现场核查要点:职责TESTINGFACILITYMANAGEMENT:Overall laboratory management and administrative functionsdesignatesstudydirectorbeforestudyisinitiatedreplacesstudydirector(promptly),ifnecessaryassuresthereisaqualityassuranceunit(QAU)assurestestandcontrolarticleshavebeenappropriatelyevaluatedforidentity,st

    26、rength,purity,stabilityanduniformity(asapplicable)现场核查要点:职责现场核查要点:职责TESTINGFACILITYMANAGEMENT:(contd)assuresappropriatestaffing,facilities,equipmentandmaterialsareavailableforscheduledtestsassuresthatstaffunderstandsthefunctionstheyaretoperformassuresdeviationsreportedbyQAUarepromptlyreportedtostudy

    27、director现场核查要点:职责现场核查要点:职责STUDYDIRECTORSingle point of study controlhasoverallresponsibilityfor:ProtocolpreparationtechnicalconductofstudyinterpretationofresultsanalysisofresultsdocumentationofresultsreportingofresultsArchiving现场核查要点:职责现场核查要点:职责STUDYDIRECTOR:(contd)Protocolpreparation现场核查要点:职责现场核查要点

    28、职责STUDYDIRECTOR:(contd)ContributorsOphthalmologyCardiologyImmunologyAnalyticalFormulationanalysisBioanalyticalStatisticalanalysisSpecialists/ConsultantsAntibodiesBonemarrowdifferentialcountsSpecializedclinicalpathologySpermAnalysis现场核查要点:职责现场核查要点:职责STUDYDIRECTOR:(contd)SpecialProceduresConsideratio

    29、nsArethereSOPsinplace?Arethestaffappropriatelytrained?Isthistrainingdocumented?Areliteraturesearchesnecessary?IACUCimplications?Doyouneedtouseaconsultant/PIforthework?现场核查要点:职责现场核查要点:职责STUDYDIRECTOR:(contd)Multi-SiteStudies*Work(i.e.phaseofaGLPstudy)performedatageographicallydistinctsite(NotaFDAGLPt

    30、erm)AssignaPItoensurecompliancewithGLPsWillsignanAcceptanceofResponsibilitiesformWillsignastatementtothisfactuponcompletionoftheworkStudydirectorremainsthesinglepointofcontrolandmaintainsresponsibilityforoverallconductQualityassuranceofthetestsite*OECDrequirement现场核查要点:职责现场核查要点:职责STUDYDIRECTOR:(cont

    31、d)StudySchedulingConsiderationsTestarticleavailabilityAnimalavailability/orderingHousingTrainedstaffAnalyticalchemistryClinicalpathologyNecropsyReports现场核查要点:职责现场核查要点:职责STUDYDIRECTOR:(contd)TestArticleCalculations-Howmuchwillyouneed?Whenisitavailable?Finaldoses?AnalyticalConfirmationStorage/handling

    32、conditionsCertificateofAnalysis(COA),MSDS,purity,stabilityIsthereadoseformulation?现场核查要点:职责现场核查要点:职责STUDYDIRECTOR:(contd)ProtocolReview&ApprovalManagementSDSponsor(ifdonebyCRO)ScientificcontributorsandlaboratorystaffReportpreparationstaffQAUIACUC现场核查要点:职责现场核查要点:职责STUDYDIRECTOR:(contd)OvetsightofStud

    33、yConductObserveanimalsandproceduresReviewdataCommunicatewithscientificcontributorsandtechnicalstaffQAauditsinternalandexternalInteractionswithcontributors/PIsSubmissionofsamplesReceipt/reviewofreportRespondtounexpectedevents现场核查要点:职责现场核查要点:职责STUDYDIRECTOR:(contd)OversightofStudyConductProtocolamendm

    34、ents-aplannedchangeProtocoldeviationsnotplanned;impactonstudymustbedeterminedSOPdeviations现场核查要点:职责现场核查要点:职责STUDYDIRECTOR:(contd)ExampleofDocumentationProtocol/protocolamendmentProtocol/SOPdeviationsAnimalorderTestarticlereceipt/informationTestarticlepreparationprocedureDoseaccountability(outofrange

    35、)StudyfilenotesVeterinaryrequests/approvaloftreatmentEnvironmentaldeviations(e.g.light/darkcycleandhumidity)observationsofanimals/proceduresDatareviewCorrespondenceemail,fax,letter,telephonecallsReports现场核查要点:职责现场核查要点:职责STUDYDIRECTOR:(contd)ReportPreparation现场核查要点:职责现场核查要点:职责STUDYDIRECTOR:(contd)Ar

    36、chivingProtocol/amendmentsRawdataDocumentationSpecimensFinalreport现场核查要点:职责现场核查要点:职责STUDYDIRECTOR:(contd)SDResponsibilitiesforaFinalReportDatainterpretationPreliminarydraftaudited?unaudited?Integrationoftoxicology,pathology,TKandothersupportivedataContributingScientist/PIreportsStopped/suspendedprog

    37、ramsGLPcomplianceDeviationsandimpactondata现场核查要点:职责现场核查要点:职责STUDYDIRECTOR:(contd)assuresthat:protocol,includinganychanges,isapprovedasspecifiedinGLPs,andisfollowedallexperimentaldata,includingobservationsofunanticipatedresponsesofthetestsystem,areaccuratelyrecordedandverifiedunforeseencircumstances,

    38、thatmayaffectthequalityandintegrityofthestudy,arenotedwhentheyoccur,andthatcorrectiveactionistakenanddocumented现场核查要点:职责现场核查要点:职责QUALITYASSURANCEUNIT(QAU):Oversees GLPCompliance in laboratoryresponsibleformonitoringeachstudyforGLPcomplianceorganizationally,QAUreportstotestfacilitymanagementindepende

    39、ntofthepersonnelengagedinthedirectionandconductofindividualstudiesassuresthatfacilities,equipment,personnel,methods,practices,records,andcontrolsareinconformancewiththeGLPs现场核查要点:职责现场核查要点:职责QUALITYASSURANCEUNIT(QAU):(contd)Oversees GLP compliance in laboratorykeepsup-to-daterecordsofallstudiesschedu

    40、led/performedwithmasterscheduleatlabmaintainscopiesofallstudyprotocols现场核查要点:职责现场核查要点:职责QUALITYASSURANCEUNIT(QAU):(contd)Inspectsstudiesatintervalsadequatetoassuretheintegrityofthestudymaintainswrittenandproperlysignedrecordsateachinspectionidentifyingdateofinspectionthestudyinspectedphaseorsegmento

    41、fstudyinspectedpersonperforminginspection现场核查要点:职责现场核查要点:职责QUALITYASSURANCEUNIT(QAU):(contd)maintainswrittenandproperlysignedrecordsateachinspectionidentifyingfindingsandproblemsobservedduringinspectionscheduleddateforreinspection,ifapplicableproblemsmustimmediatelybebroughttoattentionofstudydirecto

    42、randmanagement现场核查要点:职责现场核查要点:职责QUALITYASSURANCEUNIT(QAU):(contd)submitsperiodicstatusreportsoneachstudytomanagementandstudydirectornotesproblemsnotescorrectiveactionstakendeterminesthatnodeviationfromapprovedprotocolsorstandardsoperatingproceduresweremadewithoutproperauthorizationanddocumentation现场

    43、核查要点:职责现场核查要点:职责QUALITYASSURANCEUNIT(QAU):(contd)Reviewsfinalstudyreporttoassurethat:reportaccuratelydescribesmethodsandstandardoperatingproceduresreportedresultsaccuratelyreflectthestudysrawdataPreparesandsignsstatementstobeincludedwiththefinalreportspecifyingdetailsoninspections现场核查要点:职责现场核查要点:职责F

    44、acilityOperationsStandardoperatingprocedures(SOP)CompleteandcomprehensiveUptodateSoundscienceandpracticalReagentsandsolutionsIdentity,titer/concentration,storagerequirements,andexpirationdateAnimalcareandIACUCMajorissuesofdataauditWhatdowelookforwhileauditingaGLPlabStudyDirectorFacilityManagementQua

    45、lityAssuranceChemistryPathology(Clinicalandanatomical)TechnicalStaffReportwritingSponsorAccountingSubcontractors非临床实验室常见错误非临床实验室常见错误StudydirectorFailuretofollowprotocolMostcommonbecauseeverythingisdrivenbyprotocol.Examples:TAStabilitydeterminationEnvironmentalconditionsExposuretotestarticle(dosing)非

    46、临床实验室常见错误非临床实验室常见错误Studydirector(contd)FinalReportCommonlyseefailurestoaddressissuesthatoccurredduringstudythatcouldaffectoutcomes非临床实验室常见错误非临床实验室常见错误Studydirector(contd)FailuretorecordalldataandverifyFormulationDosing非临床实验室常见错误非临床实验室常见错误Studydirector(contd)DocumentationissuesBestway,protocolamendme

    47、nt.Mustbedonebeforeaction(signedbySDandalsoQA,managementandsponsor).Secondbest,deviationreport(deviationfromprotocolorSOP).Completedafter-the-factbypersonmakingtheobservation(signedbySDandalsoQAandmanagement).Deviationisnotedinstudyreportalongwithdescriptionoftheimpactthedeviationhasonstudyintegrity

    48、非临床实验室常见错误非临床实验室常见错误InconsistencieswithinaprotocolorbetweenprotocolandSOPOmissionofnecessaryinformationfromprotocolLateentriesinstudybooksNonGLPcorrectionsFailuretosignanddateentriesExpiredreagents非临床实验室常见错误非临床实验室常见错误FailuretoissuetimelyprotocolamendmentsanddeviationreportsPaperworkmissingfromstudy

    49、bookInconsistenciesbetweenprotocolandreportorrawdataandreport.非临床实验室常见错误非临床实验室常见错误QAUfailstoauthorizedeviationDeviationsnotdetectedbytheQAU,butshouldhavebeen非临床实验室常见错误非临床实验室常见错误Transferofdata,specimens,recordstoarchivesAtcompletionofstudyNotallrecordstransferred非临床实验室常见错误非临床实验室常见错误DidnotfollowSOPsfo

    50、rrequiredauditingInappropriatetrainingrecordkeepingEquipmentcalibrationissuesSanitationcage/roomdisinfectantsWatersystemattachedtocagerackGLPornotGLPSafetyPharmacologystudies,Core/GLP,followupstudiesdependingonthedesign/nonGLPPrimaryPharmacodynamic/non-GLP,SecondaryPD/nonGLPunlesscontributetothesafe


    注意事项

    本文(药品研究中GLP实验室实验原始记录审核技术要求.ppt)为本站会员(peixunshi0)主动上传,三一文库仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知三一文库(点击联系客服),我们立即给予删除!




    宁ICP备18001539号-1

    三一文库
    收起
    展开